Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs Kox

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
Shock (Augusta, Ga.)|January 12, 2018
Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in SepsisChristopher Geven, Andreas Bergmann, Matthijs Kox, et al.
Critical Care (London, England)|June 24, 2024
Desorption in hemoadsorption therapies: a call for more dataAron Jansen, Nicole Waalders, Matthijs Kox, et al.
The American Journal of Case Reports|April 2, 2025
Two Case Reports of Interferon-γ Therapy in Patients with Aspergillus Tracheobronchitis Who Developed an Immunocompromised State After Severe Abdominal SepsisTeun Tramper, Jeroen Schouten, Matthijs Kox, et al.
Journal of Clinical Anesthesia|August 25, 2016
Preoperative use of anxiolytic-sedative agents; are we on the right track?Martin J L Bucx, Piet Krijtenburg, Matthijs Kox
Shock (Augusta, Ga.)|December 31, 2015
Plasma Nuclear and Mitochondrial DNA Levels, and Markers of Inflammation, Shock, and Organ Damage in Patients with Septic ShockKim Timmermans, Matthijs Kox, Gert Jan Scheffer, et al.
Shock (Augusta, Ga.)|October 30, 2015
DANGER IN THE INTENSIVE CARE UNIT: DAMPS IN CRITICALLY ILL PATIENTSKim Timmermans, Matthijs Kox, Gert Jan Scheffer, et al.
European Journal of Anaesthesiology|February 1, 2022
The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort studyDirk van Lier, Remi Beunders, Matthijs Kox, et al.
Journal of Critical Care|July 23, 2023
Associations of dipeptidyl-peptidase 3 with short-term outcome in a mixed admission ICU-cohortDirk van Lier, Remi Beunders, Matthijs Kox, et al.
Expert Review of Clinical Immunology|December 22, 2018
New frontiers in precision medicine for sepsis-induced immunoparalysisNiklas Bruse, Guus P Leijte, Peter Pickkers, et al.
Vascular Pharmacology|November 23, 2006
Inhibition of Src family tyrosine kinases prevents lipopolysaccharide-induced hyporeactivity in isolated rat tail arteriesMatthijs Kox, Sumangali Wijetunge, Peter Pickkers, et al.
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
Shock (Augusta, Ga.)|January 12, 2018
Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in SepsisChristopher Geven, Andreas Bergmann, Matthijs Kox, et al.
Critical Care (London, England)|June 24, 2024
Desorption in hemoadsorption therapies: a call for more dataAron Jansen, Nicole Waalders, Matthijs Kox, et al.
The American Journal of Case Reports|April 2, 2025
Two Case Reports of Interferon-γ Therapy in Patients with Aspergillus Tracheobronchitis Who Developed an Immunocompromised State After Severe Abdominal SepsisTeun Tramper, Jeroen Schouten, Matthijs Kox, et al.
Journal of Clinical Anesthesia|August 25, 2016
Preoperative use of anxiolytic-sedative agents; are we on the right track?Martin J L Bucx, Piet Krijtenburg, Matthijs Kox
Shock (Augusta, Ga.)|December 31, 2015
Plasma Nuclear and Mitochondrial DNA Levels, and Markers of Inflammation, Shock, and Organ Damage in Patients with Septic ShockKim Timmermans, Matthijs Kox, Gert Jan Scheffer, et al.
Shock (Augusta, Ga.)|October 30, 2015
DANGER IN THE INTENSIVE CARE UNIT: DAMPS IN CRITICALLY ILL PATIENTSKim Timmermans, Matthijs Kox, Gert Jan Scheffer, et al.
European Journal of Anaesthesiology|February 1, 2022
The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort studyDirk van Lier, Remi Beunders, Matthijs Kox, et al.
Journal of Critical Care|July 23, 2023
Associations of dipeptidyl-peptidase 3 with short-term outcome in a mixed admission ICU-cohortDirk van Lier, Remi Beunders, Matthijs Kox, et al.
Expert Review of Clinical Immunology|December 22, 2018
New frontiers in precision medicine for sepsis-induced immunoparalysisNiklas Bruse, Guus P Leijte, Peter Pickkers, et al.
Vascular Pharmacology|November 23, 2006
Inhibition of Src family tyrosine kinases prevents lipopolysaccharide-induced hyporeactivity in isolated rat tail arteriesMatthijs Kox, Sumangali Wijetunge, Peter Pickkers, et al.
Pageof 20